These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2723133)

  • 1. Melatonin mediates the antidyskinetic effects of naloxone in tardive dyskinesia.
    Sandyk R; Fisher H
    J Clin Psychopharmacol; 1989 Apr; 9(2):147-8. PubMed ID: 2723133
    [No Abstract]   [Full Text] [Related]  

  • 2. Naloxone and naltrexone in mental illness and tardive dyskinesia.
    Volavka J; Anderson B; Koz G
    Ann N Y Acad Sci; 1982; 398():97-102. PubMed ID: 6760771
    [No Abstract]   [Full Text] [Related]  

  • 3. Naloxone in tardive dyskinesia.
    Blum I; Nisipeanu PF; Roberts E
    Psychopharmacology (Berl); 1987; 93(4):538. PubMed ID: 3124188
    [No Abstract]   [Full Text] [Related]  

  • 4. Peptide neurotransmitters and their implications for the treatment of tardive dyskinesia.
    Blum I; Korczyn AD
    Mod Probl Pharmacopsychiatry; 1983; 21():187-95. PubMed ID: 6197639
    [No Abstract]   [Full Text] [Related]  

  • 5. Tardive dyskinesia and the pineal gland.
    Sandyk R
    Int J Neurosci; 1988 Nov; 43(1-2):111-4. PubMed ID: 3063681
    [No Abstract]   [Full Text] [Related]  

  • 6. Naloxone and tardive dyskinesia.
    Sandyk R; Snider SR
    Biol Psychiatry; 1985 Dec; 20(12):1335-6. PubMed ID: 4063426
    [No Abstract]   [Full Text] [Related]  

  • 7. The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia.
    Stoessl AJ; Polanski E; Frydryszak H
    Mov Disord; 1993 Oct; 8(4):445-52. PubMed ID: 7901759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective function of the pineal gland in tardive dyskinesia.
    Sandyk R; Fisher H
    Int J Neurosci; 1988 Dec; 43(3-4):215-8. PubMed ID: 3243679
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of high dose naloxone to relieve tardive dyskinesia.
    Newhouse PA; Tariot PN; Gross M; Murphy DL; Cohen RM
    J Clin Psychopharmacol; 1987 Oct; 7(5):364-5. PubMed ID: 3680616
    [No Abstract]   [Full Text] [Related]  

  • 10. The relationship of serotonin metabolism and melatonin secretion to the pathophysiology of tardive dyskinesia.
    Sandyk R; Fisher H
    Int J Neurosci; 1989 Sep; 48(1-2):133-6. PubMed ID: 2583928
    [No Abstract]   [Full Text] [Related]  

  • 11. Naloxone may be beneficial in the treatment of tardive dyskinesia.
    Blum I; Munitz H; Shalev A; Roberts E
    Clin Neuropharmacol; 1984; 7(3):265-7. PubMed ID: 6386154
    [No Abstract]   [Full Text] [Related]  

  • 12. Naloxone, tardive dyskinesia, and endogenous beta-endorphin.
    Reker D; Anderson B; Yackulic C; Cooper TB; Banay-Schwartz M; Leon C; Volavka J
    Psychiatry Res; 1982 Dec; 7(3):321-4. PubMed ID: 6298849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose naloxone in tardive dyskinesia.
    Lindenmayer JP; Gardner E; Goldberg E; Opler LA; Kay SR; van Praag HM; Weiner M; Zukin S
    Psychiatry Res; 1988 Oct; 26(1):19-28. PubMed ID: 3070611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia in bipolar disorders: possible role of pineal melatonin.
    Sandyk R
    Int J Neurosci; 1990 Jun; 52(3-4):233-8. PubMed ID: 2269610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enkephalin, morphine, and naloxone in tardive dyskinesia.
    Bjørndal N; Casey DE; Gerlach J
    Psychopharmacology (Berl); 1980; 69(2):133-6. PubMed ID: 6779305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mood-dependent fluctuations in the severity of tardive dyskinesia and psoriasis vulgaris in a patient with schizoaffective disorder: possible role of melatonin.
    Sandyk R; Pardeshi R
    Int J Neurosci; 1990 Feb; 50(3-4):215-21. PubMed ID: 2265899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy.
    Thaker GK; Nguyen JA; Strauss ME; Jacobson R; Kaup BA; Tamminga CA
    Am J Psychiatry; 1990 Apr; 147(4):445-51. PubMed ID: 1969244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is melatonin treatment effective for tardive dyskinesia?
    Shamir E; Barak Y; Plopsky I; Zisapel N; Elizur A; Weizman A
    J Clin Psychiatry; 2000 Aug; 61(8):556-8. PubMed ID: 10982197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midification of tardive dyskinesia and spasmodic torticollis by apomorphine. Possible role of dopamine autoreceptors.
    Tolosa ES
    Arch Neurol; 1978 Jul; 35(7):459-62. PubMed ID: 666598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of melatonin on orofacial movements in rats.
    Abílio VC; Vera JA; Ferreira LS; Duarte CR; Carvalho RC; Grassl C; Martins CR; Torres-Leite D; Bignotto M; Tufik S; Ribeiro Rde A; Frussa-Filho R
    Psychopharmacology (Berl); 2002 Jun; 161(4):340-7. PubMed ID: 12073160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.